Changes in proteoglycan metabolism in osteochondrotic articular cartilage of growing foals.

The research paper looks into the changes in proteoglycan metabolism in the articular cartilage of growing foals affected by osteochondrosis, a skeletal disorder that hampers endochondral ossification. Using foals of 5 and 11 months old, the paper suggests that the disorder affects proteoglycan synthesis and thus impacts the integrity of the extracellular matrix of cartilage.

Research Objective

• The primary aim of this research was to investigate the differences in proteoglycan metabolism in normal and osteochondrotic articular-epiphyseal cartilage extracted from the hock and stifle joints of 43 foals aged 5 and 11 months. Proteoglycans form a major component of the cartilage’s extracellular matrix and are able to bind calcium, hence thought to play a crucial role early in the mineralisation process.

Methodology

• The researchers conducted an ex vivo study, culturing the harvested cartilage samples as explants. They measured the incorporation of 35S-[sulphate], release of newly synthesised and endogenous proteoglycans, and content of DNA and proteoglycans both ex vivo and after a 4-day period of serum stimulation.

Key Findings

• The results showed that in osteochondrotic cartilage of foals aged both 5 and 11 months, the synthesis of proteoglycans was less stimulated by serum as compared to normal cartilage. This leads to the inference that osteochondrotic chondrocytes are less vital.
• In 11-month old foals, the study found a decreased ex vivo proteoglycan production and increased turnover of newly synthesised proteoglycans in osteochondrotic cartilage, without a change in the release of endogenous proteoglycans.
• The increase in turnover of newly synthesised proteoglycans indicates a change in the composition of the proteoglycan pool.

Conclusion

• The paper concludes that an abnormal proteoglycan synthesis pattern is more likely to be a result rather than a cause of the impaired endochondral ossification of osteochondrotic lesions, considering the late changes in proteoglycan synthesis.